AIMS: To examine a relationship between alterations of structure and function of the arterial wall in response to glucose-lowering therapy in type 2 diabetes mellitus (DM) after a 1-year follow-up (FU). METHODS AND RESULTS: In DM (n = 22) and in healthy controls (n = 17), coronary artery calcification (CAC) was assessed with electron beam tomography and carotid intima-media thickness (IMT) with ultrasound, whereas coronary function was determined with positron emission tomography-measured myocardial blood flow (MBF) at rest, during cold pressor testing (CPT), and during adenosine stimulation at baseline and after FU. The decrease in plasma glucose in DM after a mean FU of 14 +/- 1.9 months correlated with a lower progression of CAC and carotid IMT (r = 0.48, P < or = 0.036 and r = 0.46, P < or = 0.055) and with an improvement in endothelium-related DeltaMBF to CPT and to adenosine (r = 0.46, P < or = 0.038 and r = 0.36, P < or = 0.056). After adjusting for metabolic parameters by multivariate analysis, the increases in DeltaMBF to CPT after glucose-lowering treatment remained a statistically significant independent predictor of the progression of CAC (P < or = 0.001 by one-way analysis of variance). CONCLUSION: In DM, glucose-lowering treatment may beneficially affect structure and function of the vascular wall, whereas the observed improvement in endothelium-related coronary artery function may also mediate direct preventive effects on the progression of CAC.
AIMS: To examine a relationship between alterations of structure and function of the arterial wall in response to glucose-lowering therapy in type 2 diabetes mellitus (DM) after a 1-year follow-up (FU). METHODS AND RESULTS: In DM (n = 22) and in healthy controls (n = 17), coronary artery calcification (CAC) was assessed with electron beam tomography and carotid intima-media thickness (IMT) with ultrasound, whereas coronary function was determined with positron emission tomography-measured myocardial blood flow (MBF) at rest, during cold pressor testing (CPT), and during adenosine stimulation at baseline and after FU. The decrease in plasma glucose in DM after a mean FU of 14 +/- 1.9 months correlated with a lower progression of CAC and carotid IMT (r = 0.48, P < or = 0.036 and r = 0.46, P < or = 0.055) and with an improvement in endothelium-related DeltaMBF to CPT and to adenosine (r = 0.46, P < or = 0.038 and r = 0.36, P < or = 0.056). After adjusting for metabolic parameters by multivariate analysis, the increases in DeltaMBF to CPT after glucose-lowering treatment remained a statistically significant independent predictor of the progression of CAC (P < or = 0.001 by one-way analysis of variance). CONCLUSION: In DM, glucose-lowering treatment may beneficially affect structure and function of the vascular wall, whereas the observed improvement in endothelium-related coronary artery function may also mediate direct preventive effects on the progression of CAC.
Authors: Thomas H Schindler; Roxana Campisi; Deborah Dorsey; John O Prior; Manfred Olschewski; James Sayre; Heinrich R Schelbert Journal: Eur Heart J Date: 2009-02-26 Impact factor: 29.983
Authors: Robert C Detrano; Melissa Anderson; Jennifer Nelson; Nathan D Wong; J Jeffrey Carr; Michael McNitt-Gray; Diane E Bild Journal: Radiology Date: 2005-06-21 Impact factor: 11.105
Authors: John O Prior; Manuel J Quiñones; Miguel Hernandez-Pampaloni; Alvaro D Facta; Thomas H Schindler; James W Sayre; Willa A Hsueh; Heinrich R Schelbert Journal: Circulation Date: 2005-04-25 Impact factor: 29.690
Authors: Thomas H Schindler; Alvaro D Facta; John O Prior; Jerson Cadenas; Xiao-Li Zhang; Yanjie Li; James Sayre; Jonathan Goldin; Heinrich R Schelbert Journal: Eur J Nucl Med Mol Imaging Date: 2008-08-15 Impact factor: 9.236
Authors: Markus Juonala; Mika Kähönen; Tomi Laitinen; Nina Hutri-Kähönen; Eero Jokinen; Leena Taittonen; Matti Pietikäinen; Hans Helenius; Jorma S A Viikari; Olli T Raitakari Journal: Eur Heart J Date: 2007-12-12 Impact factor: 29.983
Authors: Stephen J Nicholls; E Murat Tuzcu; Srinivasa Kalidindi; Kathy Wolski; Keon-W Moon; Ilke Sipahi; Paul Schoenhagen; Steven E Nissen Journal: J Am Coll Cardiol Date: 2008-07-22 Impact factor: 24.094
Authors: Steven E Nissen; Stephen J Nicholls; Kathy Wolski; Richard Nesto; Stuart Kupfer; Alfonso Perez; Horacio Jure; Robert De Larochellière; Cezar S Staniloae; Kreton Mavromatis; Jacqueline Saw; Bo Hu; A Michael Lincoff; E Murat Tuzcu Journal: JAMA Date: 2008-03-31 Impact factor: 56.272